Medtech veteran Moffit to chair Microvisk board; CFO also appointed
This article was originally published in Clinica
UK diagnostics company Microvisk Technologies has elected medtech veteran Bill Moffit chairman. Mr Moffit's knowledge, especially in blood analysis and nanotechnology, is particularly relevant to Microvisk, which has developed a handheld system for monitoring the blood clotting status of patients on the blood-thinning drug warfarin. Mr Moffit is currently president and CEO of Nanosphere, a US company developing nanotechnology-based diagnostics. Prior to this, he was president and CEO of i-STAT, a specialist in near-patient blood analysis which was bought by Abbott in 2003. Mr Moffit has also held various executive positions in Baxter Healthcare.